KEYSER D JEFFREY
Insider CIK 1393516 · ZSPH See Remarks, Director · LTRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LTRN Lantern Pharma Inc. | P Buy deriv | 2026-05-12 | 2026-05-14 | 48,544 | — | $0 | 48,544 | SEC↗ |
| LTRN Lantern Pharma Inc. | P Buy | 2026-05-12 | 2026-05-14 | 48,544 | $2.06 | $100.0K | 94,303 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2026-01-09 | 2026-01-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2026-01-09 | 2026-01-13 | 28,844 | — | $0 | 28,844 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise deriv | 2024-07-24 | 2024-07-26 | 3,832 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | X Exercise | 2024-07-24 | 2024-07-26 | 3,832 | $3.13 | $12.0K | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2024-07-15 | 2024-07-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| LTRN Lantern Pharma Inc. | D To issuer deriv | 2021-11-04 | 2025-09-23 | 3,200 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2021-11-04 | 2025-09-23 | 3,200 | — | $0 | 3,200 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2021-11-04 | 2021-11-08 | 3,200 | — | $0 | 3,200 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2020-06-15 | 2025-09-23 | 9,135 | — | $0 | 9,135 | SEC↗ |
| LTRN Lantern Pharma Inc. | D To issuer deriv | 2020-06-15 | 2025-09-23 | 9,135 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion deriv | 2020-06-15 | 2020-06-15 | 18,349 | — | $0 | 0 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2020-06-15 | 2020-06-15 | 9,135 | — | $0 | 9,135 | SEC↗ |
| LTRN Lantern Pharma Inc. | C Conversion | 2020-06-15 | 2020-06-15 | 31,927 | — | $0 | 41,927 | SEC↗ |
| LTRN Lantern Pharma Inc. | P Buy | 2020-06-11 | 2020-06-15 | 10,000 | $15.00 | $150.0K | 10,000 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 1,150 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 175,481 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 35,096 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 15,076 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 1,799 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 50,694 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 31,887 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 24,603 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 41,788 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 136,485 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer | 2015-12-17 | 2015-12-21 | 12,353 | $90.00 | $1.11M | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | U Tender | 2015-12-17 | 2015-12-21 | 216,169 | $90.00 | $19.46M | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | M Exercise deriv | 2015-12-09 | 2015-12-11 | 9,154 | — | $0 | 24,603 | SEC↗ |
| ZSPH ZS Pharma, Inc. | M Exercise | 2015-12-09 | 2015-12-11 | 9,154 | $10.92 | $100.0K | 225,323 | SEC↗ |
| ZSPH ZS Pharma, Inc. | A Award deriv | 2015-06-18 | 2015-06-25 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ZSPH ZS Pharma, Inc. | A Award deriv | 2015-06-18 | 2015-06-25 | 16,875 | $55.57 | $937.7K | 16,875 | SEC↗ |
| ZSPH ZS Pharma, Inc. | A Award deriv | 2014-07-08 | 2014-07-10 | 33,037 | — | $0 | 33,037 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion deriv | 2014-06-23 | 2014-06-25 | 12,186 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion deriv | 2014-06-23 | 2014-06-25 | 9,005 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion deriv | 2014-06-23 | 2014-06-25 | 48,744 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion | 2014-06-23 | 2014-06-25 | 21,191 | — | $0 | 167,425 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion | 2014-06-23 | 2014-06-25 | 48,744 | — | $0 | 48,744 | SEC↗ |